Glenview Trust’s Putnam BioRevolution ETF SYNB Stock Holding History

Glenview Trust’s Portfolio SYNB Stock Details SYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-69,185	Closed	-$2.01M	–	484
2023 Q4	$2.01M	Buy	+69,185	New	+$1.85M	0.05%	194

Other funds holding SYNB

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Glenview Trust's SYNB Position: Q1 2024 in Review

Glenview Trust sold out of Putnam BioRevolution ETF (SYNB) in Q1 2024, closing a stake of 69,185 shares — an estimated $2.01M sold.

Glenview Trust first reported a position in SYNB in Q4 2023 and held it in 1 quarter. The position peaked at $2.01M in Q4 2023. 3 funds tracked by Wall St. Rank hold SYNB as of Q1 2024.

Glenview Trust reported no remaining Putnam BioRevolution ETF position as of Q1 2024 after selling out during the quarter.
Glenview Trust sold 69,185 Putnam BioRevolution ETF shares in Q1 2024, an estimated $2.01M.
Glenview Trust first reported a position in Putnam BioRevolution ETF in Q4 2023 and held it in 1 quarter.
Glenview Trust's Putnam BioRevolution ETF position peaked at $2.01M in Q4 2023.
3 funds tracked by Wall St. Rank held Putnam BioRevolution ETF as of Q1 2024.

Based on Glenview Trust's 13F filing for Q1 2024, filed 14 May 2024.